138 related articles for article (PubMed ID: 25069239)
1. Involvement of sigma 1 receptor in the SSRI-induced suppression of the methamphetamine-induced behavioral sensitization and rewarding effects in mice.
Rahmadi M; Mori T; Kanazawa M; Kubota H; Shibasaki M; Suzuki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Apr; 33(2):49-56. PubMed ID: 25069239
[TBL] [Abstract][Full Text] [Related]
2. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
Ishima T; Fujita Y; Hashimoto K
Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523
[TBL] [Abstract][Full Text] [Related]
3. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.
Hashimoto K; Fujita Y; Iyo M
Neuropsychopharmacology; 2007 Mar; 32(3):514-21. PubMed ID: 16495935
[TBL] [Abstract][Full Text] [Related]
4. Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding.
Bhuiyan MS; Tagashira H; Fukunaga K
Eur J Pharmacol; 2011 Jan; 650(2-3):621-8. PubMed ID: 21044620
[TBL] [Abstract][Full Text] [Related]
5. Involvement of sigma 1 receptors in methamphetamine-induced behavioral sensitization in rats.
Takahashi S; Miwa T; Horikomi K
Neurosci Lett; 2000 Jul; 289(1):21-4. PubMed ID: 10899399
[TBL] [Abstract][Full Text] [Related]
6. Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions.
Bhuiyan MS; Tagashira H; Shioda N; Fukunaga K
Expert Opin Ther Targets; 2010 Oct; 14(10):1009-22. PubMed ID: 20722474
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine.
Kaneko Y; Kashiwa A; Ito T; Ishii S; Umino A; Nishikawa T
Neuropsychopharmacology; 2007 Mar; 32(3):658-64. PubMed ID: 16738540
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.
Nishimura T; Ishima T; Iyo M; Hashimoto K
PLoS One; 2008 Jul; 3(7):e2558. PubMed ID: 18596927
[TBL] [Abstract][Full Text] [Related]
9. Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice.
Tagashira H; Bhuiyan S; Shioda N; Hasegawa H; Kanai H; Fukunaga K
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1535-45. PubMed ID: 20802134
[TBL] [Abstract][Full Text] [Related]
10. Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders.
Albayrak Y; Hashimoto K
Adv Exp Med Biol; 2017; 964():153-161. PubMed ID: 28315270
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interaction with the sigma1 (σ1)-receptor in the acute behavioral effects of antidepressants.
Villard V; Meunier J; Chevallier N; Maurice T
J Pharmacol Sci; 2011; 115(3):279-92. PubMed ID: 21427517
[TBL] [Abstract][Full Text] [Related]
12. Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship.
Hashimoto K
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):197-204. PubMed ID: 20021354
[TBL] [Abstract][Full Text] [Related]
13. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.
Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698
[TBL] [Abstract][Full Text] [Related]
14. Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
Wang ZY; Guo LK; Han X; Song R; Dong GM; Ma CM; Wu N; Li J
Behav Brain Res; 2021 Feb; 399():112971. PubMed ID: 33075396
[TBL] [Abstract][Full Text] [Related]
15. Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization.
Yang PP; Huang EY; Yeh GC; Tao PL
J Biomed Sci; 2006 Sep; 13(5):695-702. PubMed ID: 16865411
[TBL] [Abstract][Full Text] [Related]
16. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the behavioral effects of bupropion and psychostimulants.
Mori T; Shibasaki M; Ogawa Y; Hokazono M; Wang TC; Rahmadi M; Suzuki T
Eur J Pharmacol; 2013 Oct; 718(1-3):370-5. PubMed ID: 23993950
[TBL] [Abstract][Full Text] [Related]
18. Low doses of dextromethorphan attenuate morphine-induced rewarding via the sigma-1 receptor at ventral tegmental area in rats.
Chen SL; Hsu KY; Huang EY; Lu RB; Tao PL
Drug Alcohol Depend; 2011 Sep; 117(2-3):164-9. PubMed ID: 21320758
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.
Egashira N; Harada S; Okuno R; Matsushita M; Nishimura R; Mishima K; Iwasaki K; Orito K; Fujiwara M
Eur J Pharmacol; 2007 Jun; 563(1-3):149-54. PubMed ID: 17349995
[TBL] [Abstract][Full Text] [Related]
20. The sigma receptor ligand N-phenylpropyl-N'-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice.
Tapia MA; Sage AS; Fullerton EI; Judd JM; Hildebrant PC; Will MJ; Lever SZ; Lever JR; Miller DK
Psychopharmacology (Berl); 2020 Mar; 237(3):723-734. PubMed ID: 31822924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
